New pill aims to stop recurring chest infections in adults

NCT ID NCT06736288

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Buccalin tablets can reduce the number of lower respiratory tract infections in adults who get them often. 240 participants will receive either Buccalin or a placebo for 12 months. The goal is to see if the treatment lowers infection episodes compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER RESPIRATORY TRACT INFECTION (LRTI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AOU Policlinico G. Rodolico-San Marco

    ACTIVE_NOT_RECRUITING

    Catania, Italy

  • AOU Policlinico Tor Vergata

    ACTIVE_NOT_RECRUITING

    Roma, Italy

  • AOU Ss. Antonio E Biagio E C.Arrigo

    ACTIVE_NOT_RECRUITING

    Alessandria, Italy

  • AOU di Sassari

    RECRUITING

    Sassari, Italy

  • ASST Fatebenefratelli Sacco

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • ASST Santi Paolo e Carlo

    RECRUITING

    Milan, Italy

  • Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • Humanitas Mirasole S.p.A

    ACTIVE_NOT_RECRUITING

    Milan, Italy

  • University clinic for infectious diseases and febrile conditions, Medical Faculty, Ss Cyril and Methodius University

    RECRUITING

    Skopje, North Macedonia

More trials for these conditions

Other studies related to the condition(s) this trial covers.